Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism

Journal of Nutrition

Volumn 140, Issue 10, 2010, Pages 1736-1741

  Christensen, Karen E ^a   Wu, Qing ^a   Wang, Xiaoling ^a   Deng, Liyuan ^a   Caudill, Marie A ^b   Rozen, Rima ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; FOLIC ACID; MESSENGER RNA; METHIONINE SYNTHASE REDUCTASE; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CARBON; CHOLINE; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON METABOLISM; CONTROL GROUP; CONTROLLED STUDY; DIETARY INTAKE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FATTY LIVER; FEMALE; FOLIC ACID DEFICIENCY; GENE EXPRESSION; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; DIET; ENZYMOLOGY; GENETICS; LIVER; METABOLISM; METHYLATION;

MUS;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ANIMALS; BETAINE; BETAINE-HOMOCYSTEINE S-METHYLTRANSFERASE; CARBON; CHOLINE; DIET; FATTY LIVER; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; FOLIC ACID DEFICIENCY; GENE EXPRESSION; HOMOCYSTEINE; LIVER; MALE; METHYLATION; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICE; MICE, INBRED BALB C; RNA, MESSENGER; SEX FACTORS;

EID: 77958130827     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.124917     Document Type: Article

References (34)

1. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24:3-20.
2. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002;16:663-78.
3. Mato JM, Martinez-Chantar ML, Lu SC. Methionine metabolism and liver disease. Annu Rev Nutr. 2008;28:273-93.
4. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87:1-16.
5. Obeid R, Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett. 2009;583:1215-25.
6. Schwahn BC, Chen Z, Laryea MD, Wendel U, Lussier-Cacan S, Genest JJ, Mar M-H, Zeisel SH, Castro C, et al. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J. 2003;17:512-4.
7. Schwahn BC, Wang XL, Mikael LG, Wu Q, Cohn J, Jiang H, Maclean KN, Rozen R. Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia. Atherosclerosis. 2007;195:e100-7.
8. Kohlmeier M, da Costa KA, Fischer LM, Zeisel SH. Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc Natl Acad Sci USA. 2005;102:16025-30.
9. Halsted CH, Villanueva JA, Devlin AM, Niemela O, Parkkila S, Garrow TA, Wallock LM, Shigenaga MK, Melnyk S, et al. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc Natl Acad Sci USA. 2002;99:10072-7.
10. Li Z, Vance DE. Thematic review series: glycerolipids. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008;49:1187-94.
11. Cook RJ. Folate metabolism. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge (England): Cambridge University Press; 2001. p. 113-34.
12. Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol. 2003;18:1272-82.
13. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-95.
14. Li D, Rozen R. Maternal folate deficiency affects proliferation, but not apoptosis, in embryonic mouse heart. J Nutr. 2006;136:1774-8.
15. Knock E, Deng L, Wu Q, Leclerc D, Wang XL, Rozen R. Low dietary folate initiates intestinal tumors in mice, with altered expression of G2-M checkpoint regulators polo-like kinase 1 and cell division cycle 25c. Cancer Res. 2006;66:10349-56.
16. Knock E, Deng L, Wu Q, Lawrance AK, Wang XL, Rozen R. Strain differences in mice highlight the role of DNA damage in neoplasia induced by low dietary folate. J Nutr. 2008;138:653-8.
17. Trasler J, Deng L, Melnyk S, Pogribny I, Hiou-Tim F, Sibani S, Oakes C, Li E, James SJ, et al. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis. 2003;24:39-45.
18. Garcia-Crespo D, Knock E, Jabado N, Rozen R. Intestinal neoplasia induced by low dietary folate is associated with altered tumor expression profiles and decreased apoptosis in mouse normal intestine. J Nutr. 2009;139:488-94.
19. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.
20. Gardam MA, Mejia NR, MacKenzie RE. The NADP-dependent trifunctional methylenetetrahydrofolate dehydrogenase purified from mouse liver is immunologically distinct from the mouse NAD-dependent bifunctional enzyme. Biochem Cell Biol. 1988;66:66-70.
21. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-3.
22. Sunden SL, Renduchintala MS, Park EI, Miklasz SD, Garrow TA. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys. 1997;345:171-4.
23. Elmore CL, Wu X, Leclerc D, Watson ED, Bottiglieri T, Krupenko NI, Krupenko SA, Cross JC, Rozen R, et al. Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol Genet Metab. 2007;91:85-97.
24. Goyette P, Christensen B, Rosenblatt DS, Rozen R. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet. 1996;59:1268-75.
25. Koc H, Mar MH, Ranasinghe A, Swenberg JA, Zeisel SH. Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/ electrospray ionization-isotope dilution mass spectrometry. Anal Chem. 2002;74:4734-40.
26. Abratte CM, Wang W, Li R, Moriarty DJ, Caudill MA. Folate intake and the MTHFR C677T genotype influence choline status in young Mexican American women. J Nutr Biochem. 2008;19:158-65.
27. Che A, Cui J, Dinov ID. SOCR analyses: an instructional Java Web-based statistical analysis toolkit. JOLT. 2009;5:1-19.
28. Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Washington, DC: National Academies Press; 1998.
29. Winkels RM, Brouwer IA, Verhoef P, van Oort FV, Durga J, Katan MB. Gender and body size affect the response of erythrocyte folate to folic acid treatment. J Nutr. 2008;138:1456-61.
30. Holmes-McNary MQ, Cheng WL, Mar MH, Fussell S, Zeisel SH. Choline and choline esters in human and rat milk and in infant formulas. Am J Clin Nutr. 1996;64:572-6.
31. Jacobi HP, Baumann CA, Meek WJ. The choline content of rats on various choline-free diets. J Biol Chem. 1941;138:571-82.
32. Li Z, Agellon LB, Vance DE. Choline redistribution during adaptation to choline deprivation. J Biol Chem. 2007;282:10283-9.
33. Kulinski A, Vance DE, Vance JE. A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion. J Biol Chem. 2004;279:23916-24.
34. Fast DG, Vance DE. Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion. Biochim Biophys Acta. 1995;1258:159-68.